PT - JOURNAL ARTICLE AU - Hu, Bo AU - Yang, Wei AU - Bouanchaud, Paul AU - Chongo, Yolanda AU - Wheeler, Jennifer AU - Chicumbe, Sergio AU - Chissano, Marcos TI - Determinants of COVID-19 Vaccine Acceptability in Mozambique: The Role of Institutional Trust AID - 10.1101/2022.03.03.22271828 DP - 2022 Jan 01 TA - medRxiv PG - 2022.03.03.22271828 4099 - http://medrxiv.org/content/early/2022/03/04/2022.03.03.22271828.short 4100 - http://medrxiv.org/content/early/2022/03/04/2022.03.03.22271828.full AB - Background Vaccination plays an imperative role in protecting public health and preventing avoidable mortality. Yet, the reasons for vaccine hesitancy are not well understood. This study investigates the factors associated with the acceptability of COVID-19 vaccine in Mozambique.Methods The data came from the three waves of the COVID-19 Knowledge, Attitudes and Practices (KAP) survey which followed a cohort of 1,371 adults in Mozambique over three months (N=3,809). Data collection was through a structured questionnaire using telephone interviewing (CAPI). Multilevel regression analysis was conducted to identify the trajectories of, and the factors associated with COVID-19 vaccine acceptability.Results There was great volatility in COVID-19 vaccine acceptability over time. Institutional trust was consistently and strongly correlated with different measures of vaccine acceptability. There was a greater decline in vaccine acceptability in people with lower institutional trust. The positive correlation between institutional trust and vaccine acceptability was stronger in younger than older adults. Vaccine acceptability also varied by gender and marital status.Conclusions Vaccine acceptability is sensitive to news and information circulated in the public domain. Institutional trust is a central driver of vaccine acceptability and contributes to the resilience of the health system. Our study highlights the importance of health communication and building a trustful relationship between the general public and public institutions in the context of a global pandemic.Competing Interest StatementThe authors have declared no competing interest.Funding StatementWe are grateful for the support of the Embassy of the Kingdom of the Netherlands, Mozambique to PSI/Mozambique that made this project possible.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Mozambique Comite Nacional de Bioetica para Saude (CNBS) (reference: 439/CNBS/20) gave ethical approval for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data consist of deidentified participant data and are available upon reasonable request from the corresponding author subject to PSIs data use policy